Omega Therapeutics Analyst Ratings
Omega Therapeutics Analyst Ratings
Buy Rating Reaffirmed for Omega Therapeutics on Strong Clinical and Financial Performance
Analysts' Top Healthcare Picks: Fresenius Medical Care AG & Co. KGaA (GB:0H9X), Omega Therapeutics (OMGA)
Omega Therapeutics Analyst Ratings
Buy Rating Affirmed for Omega Therapeutics Amid Strong Financials and Promising OTX-2002 Clinical Trials
Analysts Conflicted on These Healthcare Names: Annovis Bio (ANVS), Gilead Sciences (GILD) and Omega Therapeutics (OMGA)
Omega Therapeutics Analyst Ratings
Omega Therapeutics Analyst Ratings
Piper Sandler Reiterates Overweight on Omega Therapeutics, Lowers Price Target to $9
Omega Therapeutics (OMGA) Receives a Buy From Piper Sandler
Omega Therapeutics Analyst Ratings
Piper Sandler Remains a Buy on Omega Therapeutics (OMGA)
Buy Rating on Omega Therapeutics: Innovative Obesity Treatment Through Strategic Novo Nordisk Collaboration
Wedbush Reiterates Outperform on Omega Therapeutics, Maintains $12 Price Target
Omega Therapeutics Analyst Ratings
Piper Sandler Sticks to Their Buy Rating for Omega Therapeutics (OMGA)
Omega Therapeutics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Omega Therapeutics (OMGA), Esperion (ESPR) and Aeterna Zentaris (AEZS)
Analysts Offer Insights on Healthcare Companies: Omega Therapeutics (OMGA), Rain Therapeutics (RAIN) and Kinnate Biopharma (KNTE)
No Data